UnknownNot Applicable

Prevalence of Sub-epithelial Lesions Among Patients Undergoing EGDs in Egypt

Egypt2,000 participantsStarted 2020-11-18

Plain-language summary

Subepithelial lesions (SEL) are incidentally observed in the stomach of about 0.3% of middle-aged men and women; half of these are neoplastic. The incidence of subepithelial tumors (SET) of gastrointestinal (GI) origin has risen twofold to fivefold within the past 30 years.The etiology of most SMTs cannot easily be determined by endoscopy. So, we aim to estimate the prevalence and types of sub-epithelial lesions among patients undergoing EGDs in Egypt.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Any patient with detected sub-epithelial lesion during upper endoscopy either symptomatized or accidently discovered.
✓. Patients diagnosed by EUS, CT scan or surgically removed lesions.

Exclusion criteria

✕. Patients missing follow up to reach a sure diagnosis for the lesions.
✕. Patients unfit for endoscopic procedures.

What they're measuring

Estimating the prevalence and types of sub-epithelial lesions among patients undergoing EGDs in Egypt.

Timeframe: 6 months

Trial details

NCT IDNCT04622098

SponsorKafrelsheikh University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12

View on ClinicalTrials.gov More Esophageal Neoplasms trials